Medevise

What Medevise does

Medevise Consulting is a privately held, bootstrapped boutique consultancy headquartered in Strasbourg, France, that delivers integrated clinical, regulatory, market access, and medical communications services to ophthalmic medical device companies. The firm is led by founder and President Kristine Morrill, who previously founded KAMCommunications in 2005 and Medeuronet in 2008, and brings together a team of 11 PhDs, 2 optometrists, a pharmacist, and several ophthalmologists representing 12 nationalities. Medevise operates from the NextMed innovation campus in Strasbourg, a French government-backed initiative that has received more than €1 billion in funding to support medical and surgical device development, providing the company with co-location alongside surgeons, researchers, engineers, and manufacturers.

The company's service portfolio is organized into two pillars: Evidence & Access (Clinical Services, Regulatory Services, and Market Access) and Medical Communications (Medical Writing, Content Marketing, Event Planning, Media Outreach, and Professional Education). It supports clients from first-in-human studies through post-market surveillance, with regulatory expertise spanning EU MDR and FDA pathways, HEOR and registry studies, and integrated KOL activation. Named customers include enterprise players (Alcon, Bausch, Zeiss, BVI, Sight Sciences, Rayner, Micro-Surgical Technology) and venture-stage ophthalmic companies (Neurolens, Elios Vision, Samsara Surgical, iStar, Spectrum).

Medevise generates revenue through project-based and retainer professional services engagements sold via direct, sales-led consulting relationships. The go-to-market combines direct enterprise engagement with thought leadership content, including the Oracles of Eye Innovation podcast distributed on YouTube, Spotify, and Apple Podcasts, as well as events, symposia, and European media outreach. The firm is supported by a board that includes senior ophthalmologists and medtech operators (Vance Thompson, Gerd Auffarth, Bernie Haffey, Keeley Puls-Boever, Eric J. Rothchild) and a senior management team including a Chief Business Officer (Sascha Burger) and a non-executive CFO (Paul Bikard).

Name

Medevise

Legal name

Medevise Consulting

Website

https://medevise-consulting.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Medevise Consulting is a privately held boutique consultancy that provides integrated clinical, regulatory, market access, and medical communications services to ophthalmic medical device companies, from first-in-human studies through market adoption. The firm is based in Strasbourg, France, embedded in the NextMed innovation campus, and serves both startups and multinationals such as Alcon, Zeiss, and Bausch.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Device Consulting

NAICS

Scientific Research and Development Services (5417), Public Relations Agencies (541820)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYMPAAADAD

Healthcare & Life Sciences PR

Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

SECONDARYBPAFADAJ

Healthcare & Life Sciences PR

Business & Public Services/Marketing, Advertising & PR Services/Public Relations & Communications

SECONDARYMPAAAAAJ

Healthcare/Pharma Creative Agencies

Media, Entertainment & Sports/Advertising, Marketing & PR Services/Advertising Agencies (Full-Service/Creative)

Keywords

• Ophthalmic consulting services
• Medical device regulatory affairs
• Clinical trial services
• Market access strategy
• Medical communications consulting

Headquarters

HQ city

Strasbourg

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical & Regulatory Consulting: Project-based and retainer consulting engagements providing clinical trial support, regulatory strategy, and market access services to medical device companies in ophthalmology.
2. Medical Communications Services: Strategic communications services including medical writing, publications, content creation, event planning, and professional education delivered to pharmaceutical and medical device companies.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Core offering

Medevise provides integrated clinical, regulatory, market access, and medical communications consulting services exclusively for ophthalmic medical device companies. It supports clients from first-in-human studies through regulatory approval (EU MDR, FDA) and full market adoption, combining Evidence & Access services with Medical Communications and Professional Education under one team. The firm is headquartered in Strasbourg, France as part of the NextMed innovation campus.

Product overview

Medevise Consulting is a specialized consultancy offering integrated clinical, regulatory, and medical communications services for the ophthalmology and medtech sectors. The company provides a unified portfolio of services organized into two main areas: Evidence & Access (Clinical Services, Regulatory Services, and Market Access) and Medical Communications (Medical Writing, Content Marketing, Event Planning, Media Outreach, and Professional Education). The company also produces the Oracles of Eye Innovation Podcast as a thought leadership platform. All services are designed to support clients from first-in-human studies through full-scale market adoption, combining end-to-end partnership with integrated expertise across clinical strategy and medical communications.

Differentiator

Problem solved

Functional benefit

Brands

• Oracles of Eye Innovation: A podcast exploring the journeys of entrepreneurs shaping the future of eye care. Mash-up of Medevise's Business of Eye Innovation Podcast and the Oracles of Eye Innovation webinar series, highlighting real stories behind ophthalmic innovation.

Products and services

• Clinical Services
• Regulatory Services
• Market Access Services
• Medical Writing
• Content Marketing
• Event Planning
• Media Outreach
• Professional Education
• Oracles of Eye Innovation Podcast

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• NextMedcoreStrategic or Co-development PartnerMedevise is part of NextMed, an ambitious initiative in Strasbourg, France that provides an umbrella for those involved in developing medical and surgical devices, including surgeons, researchers, engineers, and manufacturers. With more than €1 billion invested by the French government, NextMed provides a powerful platform for innovation.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Global clinical research organization with significant medical device and ophthalmology exposure. A large incumbent that competes with Medevise on enterprise-level clinical programs, with materially greater scale and geographic reach.
• Syneos Health: Integrated clinical-to-commercial CRO with a communications division. Closest large-player analog to Medevise's bundled clinical + medical communications model, though Syneos operates across all major therapeutic areas.
• Inizio Evoke: Global medical communications and commercialization platform (formerly Fishawack Health). Overlaps with Medevise's Medical Communications and Professional Education offering but at far greater scale, broader therapeutic reach, and with deep global account coverage.
• IQVIA: World's largest CRO with extensive medical device, regulatory, and real-world evidence capabilities. Competes with Medevise for large ophthalmology and medtech engagements and has the global delivery footprint Medevise lacks.

Direct peers

• MedThink Communications: Medical communications and marketing agency serving specialty pharma and medical device clients. Comparable on the medical communications, content, and professional education side of Medevise's offering, with a similar specialty-focused positioning.
• Dudnyk: Healthcare-focused advertising, branding, and medical communications agency with deep specialty therapeutics experience. Comparable to Medevise's Medical Communications practice and frequently engaged by similar medical device and specialty pharma clients.
• RCRI (Veranex): Medical device-focused clinical and regulatory services firm (now part of Veranex). Comparable to Medevise on the Evidence & Access side, particularly for medical device companies navigating FDA and EU MDR pathways.
• ORA Clinical: Ophthalmology-focused clinical research organization with deep expertise in ophthalmic drug and device trials. Closest direct competitor to Medevise's clinical services practice within the same ophthalmology vertical.
• ProPharma Group: Life sciences consulting firm providing regulatory, clinical, and compliance services to medical device and pharma companies. Overlaps directly with Medevise's regulatory and clinical services portfolio, though at a broader therapeutic scope.
• NAMSA: Medical device-focused contract research organization offering clinical, regulatory, and quality consulting services. Directly comparable to Medevise's Evidence & Access practice but with a much broader therapeutic reach; Medevise is essentially a niche ophthalmology-specialized version of NAMSA's clinical/regulatory model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@oraclesofeyeinnovation3462
• Xx.com/medevise_live
• LinkedInlinkedin.com/company/medevise-consulting

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medevise